Life sciences news
-
7 (re)new(ed) strategic partnerships push flanders.bio forward into 2022
Wednesday January 19th 2022
Read more
-
Jyseleca®▼ (Filgotinib) licensed for the treatment of adult patients with moderately to severely active ulcerative colitis in Great Britain
Wednesday January 19th 2022
Read more
-
Mithra announces positive top-line results from Donesta® Phase 3 studies in menopausal women
Friday January 14th 2022
Read more
-
BioStrand secures second VLAIO research grant
Thursday January 13th 2022
Read more
-
Biotalys and Olon enter into long-term partnership for the production of protein-based biocontrols
Wednesday January 12th 2022
Read more
-
Biohaven enters exclusive license and research collaboration agreement with KU Leuven to advance first-in-class TRPM3 antagonists for the treatment of pain
Wednesday January 12th 2022
Read more
-
Oxurion provides update on clinical pipeline progress
Friday January 7th 2022
Read more
-
Ardena expands capacity to satisfy Novavax COVID vaccine demand
Thursday January 6th 2022
Read more
-
Your news here?
-
Belgian research team uses AI to explain cell diversity in the fly brain
Thursday January 6th 2022
Read more
-
Univercells acquires SynHelix, entering into synthetic biology and the race to next-generation DNA synthesis
Thursday January 6th 2022
Read more
-
Peter Scheyltjens (52), CEO en oprichter van de Advipro Groep, geeft de fakkel door aan zijn rechterhand Toon Witvrouwen (35)
Thursday December 23rd 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator